Thomas Moehler
0000-0003-1495-8917
3 papers found
Refreshing results…
Uptake of novel therapies into first-line treatment for acute myeloid leukemia patients: EU4 + UK perspective
A phase 2 clinical trial of combined BRAF/MEK inhibition for BRAFV600E-mutated multiple myeloma
First‐line therapy with bendamustine/prednisone/bortezomib—A GMMG trial for non‐transplant eligible symptomatic multiple myeloma patients
Missing publications? Search for publications with a matching author name.